SLC38A2 and cancer: Because the anti-oxidant N-acetylcysteine (NAC) was shown to mitigate ROS production in cancer cell lines,35 we postulated that exogenous supplementation of NAC might reduce the anti-growth effects of SLC38A2 blockade.